Recent data suggest that a gene-environment interaction between smoking and the HLA shared epitope alleles plays a role in shaping the autoimmune reaction to specific citrullinated antigens. This study was undertaken to determine the effects of HLA shared epitope alleles and tobacco exposure on the immune response against various citrullinated antigens. These associations were analyzed in the anti-citrullinated protein antibody (ACPA)-positive stratum to control for the possibility that the associations found are explained by the known interaction between HLA shared epitope alleles and tobacco exposure on ACPA status.
Methods
In 661 patients with rheumatoid arthritis, reactivity against several citrullinated antigens from vimentin, fibrinogen, enolase, and myelin basic protein was determined by enzyme-linked immunosorbent assay. The effects of the HLA shared epitope alleles and tobacco exposure were assessed by logistic regression analysis.
Biologic interaction was analyzed by investigating whether the effects of the risk factors combined exhibited departure from additivity.
Results
A significant interaction between tobacco exposure and HLA shared epitope alleles was found for the presence of ACPA as reported previously. When these interaction effects were studied for several ACPA "fine specificities," significant interactions were noted for several citrullinated peptides. However, these interactions were not present after stratification for ACPA status, indicating that the interaction between tobacco exposure and HLA shared epitope alleles influences autoimmunity not to specific citrullinated antigens, but rather to ACPA development.
Conclusion
Our data indicate that the gene-environment interaction between HLA shared epitope alleles and smoking does not appear to shape the reactivity of the ACPA response. These data suggest that smoking promotes nonspecific citrullination rather than citrullination of specific antigens.
INTRODUCTION
Rheumatoid arthritis (RA) is a systemic autoimmune disease involving inflammation of the joints. The detection of anti-citrullinated protein antibodies (ACPAs), often measured by an anti-citrullinated antibody assay (anti-cyclic citrullinated peptide 2 [anti-CCP-2]), is an accepted diagnostic tool for RA. 1 Anti-CCP antibodies are highly specific for RA, can be detected years before the first clinical manifestation of RA 2, 3 , and are reported to be a good predictor of the development of RA. 4 Anti-CCP antibodies recognize multiple citrullinated peptides and proteins and are thus a collection of ACPAs. 5 Likewise, ACPAs have been shown to initiate and enhance arthritis in murine models 6, 7 , and human ACPAs are able to activate both Fc receptor-positive cells 8, 9 and the complement system, indicating that they could play a role in disease pathogenesis. 10 ACPA-positive and ACPA-negative disease have been shown to be associated with different genetic and environmental risk factors, fueling the hypothesis that different pathophysiologic mechanisms underlie these 2 separate disease subsets. 11, 12 Some types of HLA alleles, particularly HLA-DRB1 alleles encoding an amino acid sequence called the shared epitope, are known to be associated with RA susceptibility 13 , specifically susceptibility to ACPA-positive RA. 14 It has been shown that ACPAs can recognize a variety of citrullinated antigens, including citrullinated fibrinogen and citrullinated vimentin, which is also known as the Sa antigen. 15 However, not all ACPA-positive sera will recognize all citrullinated antigens, as has been shown by analyzing the reactivity against different citrullinated peptide antigens. 5, 16 In ACPA-positive patients, HLA shared epitope alleles have been shown to predispose to the development of antibodies against a peptide from citrullinated vimentin, but not to the development of antibodies recognizing a peptide from citrullinated fibrinogen. These data indicate that HLA shared epitope alleles influence not only the magnitude, but also the specificity, of the ACPA response. 17 Like the HLA shared epitope alleles, the environmental factor tobacco exposure is also known to predispose mainly to autoantibody-positive disease. 18 The combined effect of HLA shared epitope alleles and tobacco exposure has been shown to exceed the sum of their single effects, a phenomenon known as biologic interaction. [19] [20] [21] A gene-environment interaction thus exists between the HLA shared epitope alleles and tobacco exposure with regard to the development of ACPA-positive RA. This interaction displays a dose-dependent effect, as there is an even stronger gene-environment interaction present for heavy cigarette smoking. 22 Recently, it has been reported that a specific interaction exists between the presence of HLA-DRB1*04, tobacco exposure, and the specific recognition of a peptide derived from citrullinated enolase. 23 Such epidemiologic studies might be of relevance as they link established genetic and environmental risk factors to an autoimmune response against specific citrullinated antigens that are expressed in the inflamed joints of RA patients. Therefore, such findings might provide relevant clues to aid in the understanding of the pathologic mechanism underlying RA development and progression. More recently, however, we have reported a similar interaction for 2 peptides derived from 2 other citrullinated proteins, citrullinated vimentin and citrullinated fibrinogen. 24 These latter data indicate that the observed interaction might not be confined to an auto-immune response against a specific citrullinated antigen.
Rather, these findings indicate that these interaction effects extend to several citrullinated autoantigens, which might even be explained by a general predisposition to ACPA development. In this study, we aimed to analyze in greater detail the extent of the interaction between HLA shared epitope alleles and tobacco exposure on the antigen-recognition profile of ACPA, especially in ACPA-positive patients in order to exclude the possibility that the association is caused by the presence of ACPA rather than by the presence of an autoimmune reaction to specific citrullinated epitopes.
PATIENTS AND METHODS

Patient population
The patients who were analyzed in this study were derived from the Leiden Early Arthritis Clinic (EAC) cohort (n = 661). The Leiden EAC cohort is an inception cohort of patients with recent-onset arthritis (symptom duration of <2 years) that was started at the Department of Rheumatology of the Leiden University Medical Center in 1993 and has been described in detail previously. 25 All patients fulfilled the American College of Rheumatology 1987 revised criteria for the classification of RA26 within the first year of follow-up. At baseline, patients were asked by trained research nurses if they had ever or never smoked. Cumulative smoking data were not included in these analyses, due to insufficient power. The protocols were approved by the relevant local ethics committee, and informed consent was obtained from all participants.
Genotyping
DNA was collected at baseline for genotyping of the HLA-DRB1 region by polymerase chain reaction and hybridization to sequence-specific oligonucleotides as described previously. 27 The HLA-DRB1*01:01, *01:02, *04:01, *04:04, *04:05, *04:08, *10:01, and *14:02 alleles were classified as the shared epitope alleles. 
Anti-CCP-2 assays
ACPA fine specificity assays
ELISAs were developed, as previously described 17 28 Briefly, streptavidin-coated preblocked microtiter plates (Thermo Scientific)
were coated with the different fibrinogen, vimentin, and enolase peptides, followed by incubation with the serum samples. After washing, antibodies were detected with a rabbit anti-human IgG horseradish peroxidase-conjugated antibody (P0214; Dako) and ABTS as the coloring substrate, according to the recommendations of the manufacturer (Sigma-Aldrich).
Citrullination of myelin basic protein (MBP; Sigma-Aldrich) and the specific ELI-SA were performed as previously described. 29 Antibodies reactive with citrullinated MBP were determined in sera diluted 1:100.
Although there are other targets for ACPA 30, 31 we chose to primarily investigate epitopes from these proteins because they have been most consistently identified as citrullinated autoantigens. 15, 32, 33 We elected to use citrullinated MBP as a citrullinated protein antigen, since its ELISA has previously been standardized to be the clinical equivalent (positive versus negative) of the original anti-Sa (citrullinated vimentin) Western blot assay. 29 Cutoff values for the citrulline-specific responses were calculated in each assay as previously described and were defined as 3 SD above the value of the mean concentration of the serum samples obtained from 41 control patients with gout.
In fine specificity studies, citrulline-specific signals were defined as a positive signal (above the cutoff value based on findings in patients with gout) against the citrullinated antigen and a minimum difference of 0.1 in delta optical density values compared to the noncitrullinated antigen. 34 The fine specificity reactivity was confined to the subset of ACPA-positive patients. More than 98% of the patients displaying antibodies against a specific fine specificity epitope were also anti-CCP-2 positive; therefore, we did not analyze all of the anti-CCP-2-negative patients for fine specificity repertoire.
IgM rheumatoid factor was determined by ELISA. Anti-CCP2 autoantibodies (IgA 
Statistical analysis
Logistic regression analysis was performed to determine the odds ratios (ORs) and 95% confidence intervals (95% CIs) of developing autoantibody-positive RA relative to autoantibody-negative RA for the risk factors HLA shared epitope alleles and smoking. The association between the recognition of different citrullinated epitopes and a gene-environment interaction was analyzed using the same method. To take into account the effect of the known association of HLA shared epitope alleles and tobacco exposure with ACPA status, stratified analyses in ACPA-positive patients only were performed.
Biologic interaction, defined as the deviation from additivity, was evaluated by 3 measures: relative excess risk due to interaction (RERI), the attributable proportion due to interaction (AP), and the synergy index. These measures indicate significant biologic interaction if they differ from 0 (RERI and AP) or 1 (synergy index). RERI can be interpreted as the excess risk due to interaction relative to the risk without exposure. AP is interpreted as the attributable proportion of disease that is due to interaction, among persons with both exposures. The synergy index can be interpreted as the excess risk from exposure (to both exposures) when there is interaction, relative to the excess risk from exposure (to both exposures) without interaction. 35 (For a more detailed definition of these measures, see ref.
36). To obtain the parameter estimates needed for calculating these 3 measures, a logistic regression model was fitted. 21 Data were analyzed using SPSS, version 17.0. P values less than 0.05 were considered significant.
RESULTS
Effect of single risk factors on ACPA fine specificity
To investigate whether HLA shared epitope alleles and tobacco exposure are associated with specific reactivities within the total ACPA response, CCP-2 status was determined in 661 RA patients, of whom 348 were found to be anti-CCP-2 positive (Table 1 ). In baseline sera from 345 of these ACPA-positive RA patients, as well as in sera from 92 ACPA-negative RA patients, we determined reactivity against 2 citrullinated vimentin peptides (citrullinated vimentin 1-16 and citrullinated vimentin 59-74), 2 citrullinated fibrinogen peptides (citrullinated fibrinogen α and citrullinated fibrinogen β), citrullinated a-enolase peptide, and citrullinated MBP. More than 98% of the patients who were positive for a specific citrullinated epitope were also ACPA positive (Table 2 ). Among ACPA-positive RA patients, 50% displayed antibodies against citrullinated vimentin 59-74 and 12% against citrullinated vimentin 1-16. The highest percentage of reactivity was found for citrullinated fibrinogen β, for which 70% of the ACPA-positive RA patients displayed reactivity. Reactivity against the citrullinated α-enolase peptide was found in 34% of the ACPA-positive patients, and reactivity against citrullinated MBP was found in 65% of the ACPA-positive patients. Almost all ACPA-positive patients were also positive for anti-MCV and anti-CCP-3, as previously described. 37 An association between the presence of HLA shared epitope alleles and the recognition of virtually all citrullinated peptides was found when analyzing all RA patients, both ACPA-positive and ACPA-negative ( alleles influences the recognition of specific citrullinated epitopes, we performed similar analyses in the subset of ACPA-positive patients. In doing so, we controlled for the possibility that the results described above are explained by the known association between HLA shared epitope alleles and ACPA status, rather than by an influence of the HLA shared epitope alleles on specific epitope recognition. Within the subset of ACPA-positive patients, we still found a significant association between HLA shared epitope alleles and some, but not all, citrullinated epitopes (Table 4 ).
This suggests that HLA shared epitope alleles are involved in shaping the immune response against specific citrullinated antigens.
Likewise, we performed a similar analysis to investigate the association between tobacco exposure and the recognition of citrullinated peptides. This analysis revealed smaller but similar associations ( Table 3 ). The strongest association was found between citrullinated α-enolase recognition and tobacco exposure, with an OR of 3.0 (95% CI 1.9, 4.9). To analyze whether the observed association between tobacco exposure and the recognition of citrullinated epitopes was also specific for the recognition of certain epitopes, rather than due to the known association between tobacco exposure and ACPA status, we analyzed the association within the subset of ACPA-positive patients. An association between tobacco exposure and citrullinated α-enolase recognition remained (OR 1.7 [95% CI 1.1, 2.8]), while other citrullinated epitopes were no longer significantly associated with tobacco exposure (Table 4 ).
This may indicate that tobacco exposure plays a modest role in broadening the immune response against some, but not all, citrullinated antigens.
Effect of risk factor interaction on ACPA fine specificity
Next, we investigated the effect of biologic interaction between HLA shared epitope alleles and smoking with regard to ACPA fine specificity. The recognition of most fine specificity peptides indicated biologic interaction between those 2 risk factors when using ACPA-negative patients as reference ( Intriguingly, interaction effects were also noted in the subset of ACPA-positive patients who did not show reactivity against, for example, citrullinated vimentin 1-16. This observation indicated that the interactions detected are mainly explained by the known effects between HLA shared epitope alleles and tobacco exposure on ACPA status. To control for this possibility, we next stratified the patients with regard to ACPA status and performed similar analyses in the ACPA-positive patients only.
We reasoned that if the interaction only affected specific reactivities, the interaction should be detectable in the total subset of ACPA-positive patients as well. Notably, no significant effects were observed after stratification for ACPA status (Table 6 ).
For example, HLA shared epitope alleles and tobacco exposure no longer showed a significant interaction on the recognition of citrullinated vimentin 59-74, with a combined effect OR of 4.0 (95% CI 1. 7, 9.6 ) and RERI of 0.3 (95% CI -2.0, 2.6), which is comparable to the association found for HLA shared epitope alleles and citrullinated vimentin 59-74 recognition only (OR 3.7 [95% CI 2.0, 6.8]). Similar effects were observed for the other fine specificity reactivities ( Figure 1B) .
Consistent with the results presented above, the AP due to interaction was comparable among reactivities against all of the citrullinated antigens and ACPA ( Figure   3 ). Since the AP was calculated before stratification for ACPA, these results indicate that the interaction effects between tobacco exposure and HLA shared epitope alleles did not affect the fine specificity, but rather affected the ACPA status. Only citrullinated vimentin 1-16 displayed a slightly higher AP, but this might be a spurious finding due to the small number of RA patients displaying antibodies against citrullinated vimentin 1-16 (6%).
An analysis of the interaction between tobacco exposure and only HLA DRB1*04 shared epitope alleles resulted in similar findings, with strong interactive effects disappearing after stratification for ACPA status (data not shown 
DISCUSSION
Our results show that the apparent interaction between HLA shared epitope alleles and tobacco exposure for ACPA fine specificity disappears after stratification for ACPA status, indicating that this interaction does not greatly affect the fine specificity of the ACPA response. Recently, it has been suggested that a gene-environment interaction between HLA shared epitope alleles and tobacco exposure plays a role in shaping an autoimmune response specifically directed against a peptide derived from enolase. 23 Further experimentation resulted in similar findings for the recognition of other citrullinated epitopes that were derived from vimentin and fibrinogen. 24 These findings could be of relevance, since interactions between genotype, smoking, and autoimmunity to certain citrullinated antigens could further expand our understanding of RA pathogenesis.
However, no stratification for ACPA status was performed in previous studies, allowing the possibility that the interaction effects were not explained by their influence on the formation of autoimmune reactions against specific citrullinated antigens, but rather by their influence on the formation of ACPA. In the present study, we specifically investigated this possibility. Careful analyses of original data previously published by our group and by Mahdi et al 23, 24 suggested that no such interaction effects were present, since, for example, the AP was similar for ACPA-positive disease in the presence and, importantly, also in the absence of a specific ACPA reactivity. Therefore, we reasoned that if such interaction effects only shaped the response to certain specific epitopes and not to other citrullinated epitopes, these effects should still be observed among the subset of ACPA-positive patients. We showed that this is not the case; the ORs observed in the interaction analysis were similar to the ORs observed for the presence of HLA shared epitope alleles only after stratification for ACPA status.
Taken together, these data indicate that the gene-environment interaction between tobacco exposure and HLA shared epitope alleles does not influence the reactivity of the ACPA response. Rather, the presence of HLA shared epitope alleles seems to be the main factor in shaping the antigen recognition of the ACPA response. This is evidenced by the fact that the association between HLA shared epitope alleles and certain fine specificities, such as citrullinated vimentin 59-74 and citrullinated α-enolase, remained after stratification for ACPA status, as has been demonstrated previously. 17 Thus, these results suggest that ACPA fine specificity recognition is mainly dependent on HLA shared epitope status and that tobacco exposure and the interaction between HLA shared epitope alleles and tobacco exposure contribute little. These data also suggest that smoking promotes nonspecific citrullination rather than citrullination of specific antigens.
The findings of this study add to the discussion on the role of tobacco exposure and possibly other environmental triggers, such as infection with certain pathogens, in the pathogenesis of RA. For example, it has been postulated that the fact that immunity to some citrullinated antigens is strongly associated with both tobacco exposure and shared epitope alleles supports the hypothesis that smoking may induce citrullination of certainproteins in the lungs and that immunity to these posttranslationally modified proteins may be determined by certain HLA alleles. 38 This hypothesis is intriguing and warrants further investigation; it would also incriminate certain citrullinated proteins and/or epitopes in the break of tolerance against citrullinated antigens. However, the findings of the present study indicate that the presumed interaction effects previously described by our group and by Mahdi et al 23, 24 should not be taken as evidence supporting this hypothesis, but rather as evidence that the main driver of ACPA fine specificity is found in the HLA shared epitope alleles. In contrast, the interaction effects between HLA shared epitope alleles and smoking are more likely to be confined to the predisposition to ACPA-positive disease.
A potential limitation of our study is that the results were not corrected for multiple testing, allowing the possibility that some associations are false-positives.
However, the large ORs found are consistent with previously published data. 17, 23 Likewise, we cannot formally exclude the presence of an interaction between HLA shared epitope alleles and tobacco exposure for the peptides analyzed, due to insufficient power. The observed RERI for, e.g., citrullinated vimentin 59-74 (0.29
[95% CI -2.02, 2.59), is not statistically significant. 39 Clearly, a large number of patients would be needed to obtain significant RERI values. The CI surrounding this RERI further indicates that it is unlikely that an RERI of >2.6 will be found in larger studies.
Thus, even if such an interaction existed, it would be modest compared to that found in previous analyses and would not have a very strong influence on the constitution of the fine specificity repertoire. In contrast, the findings of the present study indicate that the HLA shared epitope status is mainly driving the result.
Although our data indicate that there is no clear link between environmental and genetic risk factors in the development of autoimmunity against specific citrullinated antigens, further study of other potential citrullinated autoantigens is needed.
Clearly, we cannot exclude the possibility that such an interaction is involved in the development of antibodies against other citrullinated antigens. This would especially be the case in analyses that focus on "heavy smoking," since cumulative smoking exposure might affect such presumed specific interaction. We did not perform such an analysis because of insufficient power.
Taken together, our findings indicate that gene-environment interactions play no major role in shaping the reactivity of the ACPA response by broadening the ACPA recognition profile, but rather that the HLA shared epitope alleles make a significant contribution to the ACPA recognition profile.
